Business:
Gene Editing Technology
Drug notes:
Also Clin2b IgA nephropathy; MAU868 Clin2 BK viremia in renal transplant, Clin0 BKV cystitis in HSCT
About:
Vera Therapeutics late-stage biotech company focuses on developing treatments for serious immunological, inflammatory, and rare diseases such as nephropathy. They aim to not only treat symptoms, but target the source of disease through modulation of the immune system in order to transform the standard of care for these patients. This approach could not only halt disease, but has the potential for reversal of the disease. For example, through the inhibition of cytokines, B- cells are prevented from producing disease-causing antibodies that result in kidney disease. Overall, Vera is dedicated to addressing diseases that may be altered by the inhibition of autoantibody development, while keeping sustainability in mind.
Field Medical Director - Midwest United States|11 days ago
Field Medical Director - Northeast United States|12 days ago
Associate Director, Scientific Communications and ... United States|12 days ago
Field Medical Director - West United States|12 days ago
Associate Director, Internal Communications Brisbane, CA|18 days ago
Sr Director, Patient Support Services & Patient Af... Brisbane, CA|18 days ago
Senior Director, Sales Training United States|19 days ago
********, **** ********* ********, **|24 days ago
Senior Director, Trade & Distribution Brisbane, CA|25 days ago
Director, Medical Information United States|26 days ago
Associate Director, GxP Systems Brisbane, CA|26 days ago
Associate Director, Program Management Brisbane, CA|37 days ago
Vice President, Total Rewards & Operations United States|37 days ago
Senior Vice President, Corporate Finance and Inves... Brisbane, CA|Not provided
Senior Director, Program Management United States|Not provided
Senior Medical Editor United States|Not provided
Health Outcomes Liaison United States|Not provided